BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 27097651)

  • 21. Predictive value of pentagastrin test for preoperative differential diagnosis between C-cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels.
    Milone F; Ramundo V; Chiofalo MG; Severino R; Paciolla I; Pezzullo L; Lombardi G; Colao A; Faggiano A
    Clin Endocrinol (Oxf); 2010 Jul; 73(1):85-8. PubMed ID: 20039894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved diagnostic methods in the follow-up of medullary thyroid carcinoma by highly specific calcitonin measurements.
    Engelbach M; Görges R; Forst T; Pfützner A; Dawood R; Heerdt S; Kunt T; Bockisch A; Beyer J
    J Clin Endocrinol Metab; 2000 May; 85(5):1890-4. PubMed ID: 10843170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-Term Follow-up in Medullary Thyroid Carcinoma.
    Raue F; Frank-Raue K
    Recent Results Cancer Res; 2015; 204():207-25. PubMed ID: 26494391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimizing Diagnostic Accuracy of Fine Needle Aspiration Biopsy Calcitonin Measurements in Detecting Medullary Thyroid Carcinoma.
    Cavallo AC; Pitoia F; Roberti J; Brenzoni P; Lencioni M; Jaroslavsky MJ; Spengler E; Voogd A; Firpo C; Saco P; Piñero F; Negueruela M
    Thyroid; 2024 Feb; 34(2):186-196. PubMed ID: 38047535
    [No Abstract]   [Full Text] [Related]  

  • 25. Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d'Etudes des Tumeurs a Calcitonine (GETC).
    Cohen R; Campos JM; Salaün C; Heshmati HM; Kraimps JL; Proye C; Sarfati E; Henry JF; Niccoli-Sire P; Modigliani E
    J Clin Endocrinol Metab; 2000 Feb; 85(2):919-22. PubMed ID: 10690910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of preoperative routine measurement of basal serum thyrocalcitonin in candidates for thyroidectomy due to nodular thyroid disorders: results from 2733 consecutive patients.
    Chambon G; Alovisetti C; Idoux-Louche C; Reynaud C; Rodier M; Guedj AM; Chapuis H; Lallemant JG; Lallemant B
    J Clin Endocrinol Metab; 2011 Jan; 96(1):75-81. PubMed ID: 20881258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for medullary thyroid carcinoma: experience with different immunoassays for human calcitonin.
    Bieglmayer C; Scheuba C; Niederle B; Flores J; Vierhapper H
    Wien Klin Wochenschr; 2002 Apr; 114(7):267-73. PubMed ID: 12089862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum calcitonin negative medullary thyroid carcinoma: a systematic review of the literature.
    Trimboli P; Giovanella L
    Clin Chem Lab Med; 2015 Sep; 53(10):1507-14. PubMed ID: 25781697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thyroid venous catheterization in the early diagnosis of familial medullary thyroid carcinoma.
    Wells SA; Baylin SB; Johnsrude IS; Harrington DP; Mendelsohn G; Ontjes DJ; Cooper CW
    Ann Surg; 1982 Nov; 196(5):505-11. PubMed ID: 7125737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum calcitonin nadirs to undetectable levels within 1 month of curative surgery in medullary thyroid cancer.
    Andrade F; Rondeau G; Boucai L; Zeuren R; Shaha AR; Ganly I; Vaisman F; Corbo R; Tuttle M
    Arch Endocrinol Metab; 2019; 63(2):137-141. PubMed ID: 30916162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Usefulness of preoperative serum calcitonin in patients with nodular thyroid disease without suspicious history or cytology for medullary thyroid carcinoma.
    Rosário PW; Penna GC; Brandão K; Souza BÉ
    Arq Bras Endocrinol Metabol; 2013 Jun; 57(4):312-6. PubMed ID: 23828436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ultrasonographic Features of Medullary Thyroid Carcinoma: Do they Correlate with Pre and PostOperative Calcitonin Levels?
    Cho KE; Gweon HM; Park AY; Yoo MR; Kim J; Youk JH; Park YM; Son EJ
    Asian Pac J Cancer Prev; 2016; 17(7):3357-62. PubMed ID: 27509975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The timing of total thyroidectomy in RET gene mutation carriers could be personalized and safely planned on the basis of serum calcitonin: 18 years experience at one single center.
    Elisei R; Romei C; Renzini G; Bottici V; Cosci B; Molinaro E; Agate L; Cappagli V; Miccoli P; Berti P; Faviana P; Ugolini C; Basolo F; Vitti P; Pinchera A
    J Clin Endocrinol Metab; 2012 Feb; 97(2):426-35. PubMed ID: 22162466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Influence of the calcitonin assay on the definition of biochemical cure in patients with medullary thyroid carcinoma].
    Hartung-Knemeyer V; Müller S; Nagarajah J; Lahner H; Broecker-Preuss M; Bockisch A; Görges R
    Nuklearmedizin; 2012; 51(4):125-32. PubMed ID: 22526413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spurious hypercalcitoninemia in patients with nodular thyroid disease induced by heterophilic antibodies.
    Kim JM; Chung KW; Kim SW; Choi SH; Min HS; Kim JN; Won WJ; Kim SK; Lee JI; Chung JH; Kim SW
    Head Neck; 2010 Jan; 32(1):68-75. PubMed ID: 19536770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calculation and validation of a plasma calcitonin limit for early detection of medullary thyroid carcinoma in nodular thyroid disease.
    Rink T; Truong PN; Schroth HJ; Diener J; Zimny M; Grünwald F
    Thyroid; 2009 Apr; 19(4):327-32. PubMed ID: 19355822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medullary thyroid cancer with undetectable serum calcitonin.
    Brutsaert EF; Gersten AJ; Tassler AB; Surks MI
    J Clin Endocrinol Metab; 2015 Feb; 100(2):337-41. PubMed ID: 25490273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.
    Lupone G; Antonino A; Rosato A; Zenone P; Iervolino EM; Grillo M; De Palma M
    G Chir; 2012; 33(11-12):395-9. PubMed ID: 23140924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequency and relevance of elevated calcitonin levels in patients with neoplastic and nonneoplastic thyroid disease and in healthy subjects.
    Karanikas G; Moameni A; Poetzi C; Zettinig G; Kaserer K; Bieglmayer C; Niederle B; Dudczak R; Pirich C
    J Clin Endocrinol Metab; 2004 Feb; 89(2):515-9. PubMed ID: 14764755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time to calcitonin normalization after surgery for node-negative and node-positive medullary thyroid cancer.
    Machens A; Lorenz K; Dralle H
    Br J Surg; 2019 Mar; 106(4):412-418. PubMed ID: 30725475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.